Type
. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (New York, N.Y.). 1991;254(5029):277-9.
Type
. Serology and leprosy: immunoassays comparing immunoglobulin G antibody responses to 28- and 30-kilodalton proteins purified from Mycobacterium bovis BCG. Journal of clinical microbiology [Internet]. 1991;29(10):2285-90. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270314/pdf/jcm00046-0215.pdf
Type
. Cytogenetic studies in leprosy patients before and after chemotherapy. Human genetics. 1991;87(6):665-70.
Type
. Leprosy in reaction. BMJ (Clinical research ed.) [Internet]. 1991;303(6803):647. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1671089/pdf/bmj00144-0059b.pdf
Type
. Immunopathology of leprosy skin lesions. Seminars in dermatology. 1991;10(3):188-93.
Type
. Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy. Immunological reviews. 1991;121:171-91.
Type
. Evaluation of genotoxicity of clofazimine, an antileprosy drug, in mice in vivo. III. Sister chromatid exchange analysis in bone marrow cells. In vivo (Athens, Greece). 1991;5(1):69-70.
Type
. Correction of severe foot deformities. Acta orthopaedica Belgica. 1991;57 Suppl 1:8-15.
Type
. [The campaign against leprosy]. Revue d'epidemiologie et de sante publique. 1991;39(3):326-7.
Type
. Social inequality, urban growth and leprosy in Manaus: a spatial approach. Revista de saude publica [Internet]. 2009;43(4):656-65. Available from: http://www.scielosp.org/pdf/rsp/v43n4/en_842.pdf
Pagination
- Previous page
- Page 2089
- Next page